These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8358629)

  • 1. Serotonin 5-HT3 receptors in schizophrenia: a postmortem study of the amygdala.
    Abi-Dargham A; Laruelle M; Lipska B; Jaskiw GE; Wong DT; Robertson DW; Weinberger DR; Kleinman JE
    Brain Res; 1993 Jul; 616(1-2):53-7. PubMed ID: 8358629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and regional characterization of [3H]LY278584 binding sites in human brain.
    Abi-Dargham A; Laruelle M; Wong DT; Robertson DW; Weinberger DR; Kleinman JE
    J Neurochem; 1993 Feb; 60(2):730-7. PubMed ID: 8419547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia.
    Hashimoto T; Nishino N; Nakai H; Tanaka C
    Life Sci; 1991; 48(4):355-63. PubMed ID: 1824956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific [3H]LY278584 binding to 5-HT3 recognition sites in rat cerebral cortex.
    Wong DT; Robertson DW; Reid LR
    Eur J Pharmacol; 1989 Jul; 166(1):107-10. PubMed ID: 2806363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.
    Joyce JN; Shane A; Lexow N; Winokur A; Casanova MF; Kleinman JE
    Neuropsychopharmacology; 1993 Jun; 8(4):315-36. PubMed ID: 8512620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of 5-HT3 receptors in the rat brain using [3H]LY278584.
    Gehlert DR; Gackenheimer SL; Wong DT; Robertson DW
    Brain Res; 1991 Jul; 553(1):149-54. PubMed ID: 1933271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia.
    Sumiyoshi T; Stockmeier CA; Overholser JC; Dilley GE; Meltzer HY
    Brain Res; 1996 Feb; 708(1-2):209-14. PubMed ID: 8720882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal densities of 5-HT3 receptor recognition sites in Alzheimer's disease.
    Barnes NM; Costall B; Naylor RJ; Williams TJ; Wischik CM
    Neuroreport; 1990; 1(3-4):253-4. PubMed ID: 1966609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and distribution of 5-HT3 recognition sites in the rat gastrointestinal tract.
    Champaneria S; Costall B; Naylor RJ; Robertson DW
    Br J Pharmacol; 1992 Jul; 106(3):693-6. PubMed ID: 1504752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
    Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
    Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of serotonergic ligands to brain membranes of alcohol-preferring AA and alcohol-avoiding ANA rats.
    Korpi ER; Päivärinta P; Abi-Dargham A; Honkanen A; Laruelle M; Tuominen K; Hilakivi LA
    Alcohol; 1992; 9(5):369-74. PubMed ID: 1418660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 5-HT3 receptor binding kinetics in the cortex of suicide victims are normal.
    Mann JJ; Arango V; Henteleff RA; Lagattuta TF; Wong DT
    J Neural Transm (Vienna); 1996; 103(1-2):165-71. PubMed ID: 9026370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.
    Gurevich EV; Joyce JN
    Biol Psychiatry; 1997 Oct; 42(7):529-45. PubMed ID: 9376449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M; Zhang L; Rotondo A; Sun H; Morales M
    Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
    Burnet PW; Eastwood SL; Harrison PJ
    Neuropsychopharmacology; 1996 Nov; 15(5):442-55. PubMed ID: 8914117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in characteristics of the specific binding of [3H]LY-278584, a 5-HT3-receptor antagonist, on differentiated NG108-15 cells.
    Matsushima K; Imanishi T; Asano H; Funakami Y; Wada T; Ichida S
    J Pharmacol Sci; 2010; 113(3):281-4. PubMed ID: 20606368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterisation of 5-hydroxytryptamine 3 recognition sites in human brain tissue.
    Barnes JM; Barnes NM; Costall B; Ironside JW; Naylor RJ
    J Neurochem; 1989 Dec; 53(6):1787-93. PubMed ID: 2809591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular structure and dynamics of some potent 5-HT3 receptor antagonists. Insight into the interaction with the receptor.
    Cappelli A; Donati A; Anzini M; Vomero S; De Benedetti PG; Menziani MC; Langer T
    Bioorg Med Chem; 1996 Aug; 4(8):1255-69. PubMed ID: 8879547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal serotonin depletion facilitates the enhancement of prepulse inhibition by risperidone: possible role of 5-HT(2C) receptors in the dorsal hippocampus.
    Adams W; van den Buuse M
    Neuropharmacology; 2011 Sep; 61(3):458-67. PubMed ID: 21477601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of beta-adrenergic receptor subtypes in human post-mortem brain: alterations in limbic regions of schizophrenics.
    Joyce JN; Lexow N; Kim SJ; Artymyshyn R; Senzon S; Lawrence D; Cassanova MF; Kleinman JE; Bird ED; Winokur A
    Synapse; 1992 Mar; 10(3):228-46. PubMed ID: 1313605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.